J Korean Med Assoc.  2016 Jul;59(7):523-528. 10.5124/jkma.2016.59.7.523.

Vaccination in pregnancy

• Oh MJ

• KMID: 2343866
• DOI: http://doi.org/10.5124/jkma.2016.59.7.523

Abstract

Over the past few decades, eradication and reduction of vaccine-preventable diseases through immunization has increased life expectancy by reducing mortality. Pregnant women are at risk for vaccine-preventable disease-related morbidity and mortality and adverse pregnancy outcomes, including congenital anomalies, spontaneous abortion, preterm birth, and low birth weight. In addition to providing direct maternal benefit, vaccination during pregnancy likely provides direct fetal and neonatal benefit through passive immunity. Despite the impact of immunization, vaccination in pregnancy is still inadequate. This article reviews types of vaccine and vaccines recommended during pregnancy.

Keyword

Pregnancy; Vaccine; Pregnancy outcomes; Passive immunity

MeSH Terms

Abortion, Spontaneous
Female
Humans
Immunization
Infant, Low Birth Weight
Infant, Newborn
Life Expectancy
Mortality
Pregnancy Outcome
Pregnancy*
Pregnant Women
Premature Birth
Vaccination*
Vaccines
Vaccines

Reference

1. National Foundation for Infectious Diseases. Facts about adult immunization 2009 [Internet]. Bethesda: National Foundation for Infectious Diseases;2013. cited 2016 Mar 29. Available from: http://www.nfid.org/publications/factsheets.aspx.

2. Darmstadt GL, Zaidi AK, Stoll BJ. Neonatal infections: a global perspective. In : Remington JS, Klein JO, Wilson CB, Nizet V, Maldonado YA, editors. Infectious diseases of the fetus and newborn infant. Philadelphia: Saunders/Elsevier;2011. p. 24–51.

3. Stoll BJ, Hansen N. Infections in VLBW infants: studies from the NICHD Neonatal Research Network. Semin Perinatol. 2003; 27:293–301.

4. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002; 110(2 Pt 1):285–291.

5. Okoko BJ, Enwere G, Ota MO. The epidemiology and consequences of maternal malaria: a review of immunological basis. Acta Trop. 2003; 87:193–205.

6. Lindsay L, Jackson LA, Savitz DA, Weber DJ, Koch GG, Kong L, Guess HA. Community influenza activity and risk of acute influenza-like illness episodes among healthy unvaccinated pregnant and postpartum women. Am J Epidemiol. 2006; 163:838–848.

7. Faucette AN, Unger BL, Gonik B, Chen K. Maternal vaccination: moving the science forward. Hum Reprod Update. 2015; 21:119–135.

8. Goldszmid RS, Trinchieri G. The price of immunity. Nat Immunol. 2012; 13:932–938.

9. Barber EM, Fazzari M, Pollard JW. Th1 cytokines are essential for placental immunity to Listeria monocytogenes. Infect Immun. 2005; 73:6322–6331.

10. Plotkin SA, Orenstein W, Offit PA. Vaccines. Philadelphia: Saunders;2012.

11. Swamy GK, Heine RP. Vaccinations for pregnant women. Obstet Gynecol. 2015; 125:212–226.

12. Cantu J, Tita AT. Management of influenza in pregnancy. Am J Perinatol. 2013; 30:99–103.

13. Neuzil KM, Reed GW, Mitchel EF, Simonsen L, Griffin MR. Impact of influenza on acute cardiopulmonary hospitalizations in pregnant women. Am J Epidemiol. 1998; 148:1094–1102.

14. Louie JK, Acosta M, Jamieson DJ, Honein MA. California Pandemic (H1N1) Working Group. Severe 2009 H1N1 influenza in pregnant and postpartum women in California. N Engl J Med. 2010; 362:27–35.

15. Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, Knight M. UKOSS. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ. 2011; 342:d3214.

16. Toback SL, Beigi R, Tennis P, Sifakis F, Calingaert B, Ambrose CS. Maternal outcomes among pregnant women receiving live attenuated influenza vaccine. Influenza Other Respir Viruses. 2012; 6:44–51.

17. Zaman K, Roy E, Arifeen SE, Rahman M, Raqib R, Wilson E, Omer SB, Shahid NS, Breiman RF, Steinhoff MC. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008; 359:1555–1564.

18. Benowitz I, Esposito DB, Gracey KD, Shapiro ED, Vazquez M. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010; 51:1355–1361.

19. Poehling KA, Szilagyi PG, Staat MA, Snively BM, Payne DC, Bridges CB, Chu SY, Light LS, Prill MM, Finelli L, Griffin MR, Edwards KM. New Vaccine Surveillance Network. Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol. 2011; 204:6 Suppl 1. S141–S148.

20. Centers for Disease Control and Prevention. Influenza antiviral medications: summary for clinicians [Internet]. Atlanta: Centers for Disease Control and Prevention;2014. cited 2016 Mar 29. Available from: http://www. cdc.gov/flu/professionals/antivirals/summary-clinicians.htm.

21. Kim IS, Seo YB, Hong KW, Noh JY, Choi WS, Song JY, Cho GJ, Oh MJ, Kim HJ, Hong SC, Sohn JW, Cheong HJ, Kim WJ. Perception on influenza vaccination in Korean women of childbearing age. Clin Exp Vaccine Res. 2012; 1:88–94.

22. Vitek CR, Pascual FB, Baughman AL, Murphy TV. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J. 2003; 22:628–634.

23. Edwards KM. Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination. Pediatr Infect Dis J. 2005; 24:6 Suppl. S104–S108.

24. Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women: Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep. 2013; 62:131–135.

25. Choi WS, Choi JH, Kwon KT, Seo K, Kim MA, Lee SO, Hong YJ, Lee JS, Song JY, Bang JH, Choi HJ, Choi YH, Lee DG, Cheong HJ. Committee of Adult Immunization. Korean Society of Infectious Diseases. Revised adult immunization guideline recommended by the Korean Society of Infectious Diseases, 2014. Infect Chemother. 2015; 47:68–79.

26. Sohn YM, Rho HO, Park MS, Park JH, Choi BY, Ki M, Jang WI. The changing epidemiology of hepatitis A in children and the consideration of active immunization in Korea. Yonsei Med J. 2000; 41:34–39.

27. Cho GJ, Kim YB, Kim SM, Hong HR, Kim JH, Seol HJ, Hong SC, Oh MJ, Kim HJ. Hepatitis A virus infection during pregnancy in Korea: hepatitis A infection on pregnant women. Obstet Gynecol Sci. 2013; 56:368–374.

28. Pan CQ, Lee HM. Antiviral therapy for chronic hepatitis B in pregnancy. Semin Liver Dis. 2013; 33:138–146.

29. Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, Rodewald LE, Douglas JM Jr, Janssen RS, Ward JW. Advisory Committee on Immunization Practices (ACIP) Centers for Disease Control and Prevention (CDC). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep. 2006; 55:1–33.

30. Jordan HT, Farley MM, Craig A, Mohle-Boetani J, Harrison LH, Petit S, Lynfield R, Thomas A, Zansky S, Gershman K, Albanese BA, Schaffner W, Schrag SJ. Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network, CDC. Revisiting the need for vaccine prevention of late-onset neonatal group B streptococcal disease: a multistate, population-based analysis. Pediatr Infect Dis J. 2008; 27:1057–1064.

31. Novartis. Immune response induced by a vaccine against group B Streptococcus and safety in pregnant women and their offsprings [Internet]. Bethesda: ClinicalTrials.gov;2014. cited 2016 Mar 29. Available from: http://clinicaltrials.gov/show/NCT01446289.

32. Novavax. Safety study of respiratory syncytial virus (RSV)-fusion (F) protein particle vaccine [Internet]. Bethesda: ClinicalTrials.gov;2012. cited 2016 Mar 29. Available from: http://clinicaltrials.gov/show/NCT01290419.